<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Penicillin skin testing</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Penicillin skin testing</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Penicillin skin testing</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Roland Solensky, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Elizabeth J Phillips, MD, FRCPC, FRACP, FIDSA, FAAAAI</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Anna M Feldweg, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Sep 09, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H22605785"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Penicillin skin testing is a tool used in the diagnosis of penicillin allergy. This topic will review the indications, safety, protocols, and interpretation of skin testing with penicillin and the aminopenicillins (<a class="drug drug_general" data-topicid="8673" href="/d/drug information/8673.html" rel="external">amoxicillin</a> and <a class="drug drug_general" data-topicid="8737" href="/d/drug information/8737.html" rel="external">ampicillin</a>).</p><p>An overview of allergy skin testing (for various types of allergens), a general discussion of the diagnosis of drug allergy, and the clinical manifestations of penicillin allergy, are discussed separately. (See  <a class="medical medical_review" href="/d/html/5541.html" rel="external">"Overview of skin testing for IgE-mediated allergic disease"</a> and  <a class="medical medical_review" href="/d/html/2079.html" rel="external">"An approach to the patient with drug allergy"</a> and  <a class="medical medical_review" href="/d/html/2073.html" rel="external">"Penicillin allergy: Immediate reactions"</a>.)</p><p class="headingAnchor" id="H2501922727"><span class="h1">IMMEDIATE PENICILLIN REACTIONS</span><span class="headingEndMark"> — </span>Penicillins include the following:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>The natural penicillins</strong> – <a class="drug drug_general" data-topicid="9751" href="/d/drug information/9751.html" rel="external">Penicillin V</a> (oral), <a class="drug drug_general" data-topicid="9749" href="/d/drug information/9749.html" rel="external">penicillin G</a> (parenteral), <a class="drug drug_general" data-topicid="9551" href="/d/drug information/9551.html" rel="external">benzathine penicillin</a> (intramuscular), and procaine penicillin (intramuscular)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>The antistaphylococcal penicillins</strong> – <a class="drug drug_general" data-topicid="9349" href="/d/drug information/9349.html" rel="external">Dicloxacillin</a>, <a class="drug drug_general" data-topicid="9674" href="/d/drug information/9674.html" rel="external">nafcillin</a>, <a class="drug drug_general" data-topicid="9724" href="/d/drug information/9724.html" rel="external">oxacillin</a>, and <a class="drug drug_general" data-topicid="9288" href="/d/drug information/9288.html" rel="external">cloxacillin</a></p><p class="bulletIndent1"><span class="glyph">●</span><strong>The aminopenicillins</strong> – <a class="drug drug_general" data-topicid="8673" href="/d/drug information/8673.html" rel="external">Amoxicillin</a>, <a class="drug drug_general" data-topicid="8676" href="/d/drug information/8676.html" rel="external">amoxicillin-clavulanate</a>, and <a class="drug drug_general" data-topicid="8737" href="/d/drug information/8737.html" rel="external">ampicillin</a></p><p class="bulletIndent1"><span class="glyph">●</span><strong>The extended-spectrum penicillins</strong> – Carbenicillin, ticarcillin, and <a class="drug drug_general" data-topicid="9775" href="/d/drug information/9775.html" rel="external">piperacillin</a></p><p></p><p>Allergic reactions to penicillins may be categorized based on the time of onset of symptoms. Reactions that begin within minutes to one hour of administration are classified as "immediate." Although there are exceptions, this definition captures the majority of type I, immunoglobulin E (IgE)-mediated reactions (<a class="graphic graphic_table graphicRef80466" href="/d/graphic/80466.html" rel="external">table 1</a>). Signs and symptoms of immediate reactions include flushing, pruritus, urticaria, angioedema, bronchospasm, laryngeal edema, gastrointestinal symptoms, and hypotension and shock. An array of symptoms may be seen (<a class="graphic graphic_table graphicRef100732" href="/d/graphic/100732.html" rel="external">table 2</a>). (See  <a class="medical medical_review" href="/d/html/2073.html" rel="external">"Penicillin allergy: Immediate reactions", section on 'Definition'</a>.)</p><p class="headingAnchor" id="H887308111"><span class="h1">MECHANISM OF SKIN TESTING</span><span class="headingEndMark"> — </span>Skin testing is a bioassay performed on the skin, which detects the presence of allergen-specific IgE on a patient's mast cells. When allergen is introduced into the skin of a patient during skin testing, it comes into contact with cutaneous mast cells. Binding of the allergen occurs if the patient's mast cells are coated with IgE recognizing that specific allergen. If both IgE and allergen are present in sufficient quantities, then adjacent allergen-specific IgE molecules become cross-linked on the mast cell surface, and the cells are activated.</p><p>Mast cell activation results in a positive skin test, which is a transient "wheal-and-flare" reaction within 15 to 20 minutes from application of the allergen. Patients with detectable penicillin-specific IgE on their mast cells are said to be "sensitized" to penicillin and are at high risk for an immediate allergic reaction to the drug.</p><p class="headingAnchor" id="H1537236018"><span class="h1">REFERRAL</span><span class="headingEndMark"> — </span>Systematic skin testing of patients who have a history of penicillin allergy reveals that most patients have negative prick and intradermal skin testing and will go on to have negative oral challenge. This confirms that they currently do not have an immediate or IgE-mediated penicillin allergy, meaning that they were never actually allergic or have lost the allergy over time. Reintroducing penicillin as a treatment option can decrease antibiotic costs, optimize antibiotic choices, and reduce patient complications associated with broad-spectrum antibiotics, such as infections with vancomycin-resistant enterococcus and <em>Clostridioides difficile</em>, as discussed in more detail elsewhere. (See  <a class="medical medical_review" href="/d/html/111361.html" rel="external">"Choice of antibiotics in penicillin-allergic hospitalized patients", section on 'Impact of penicillin allergy on care'</a>.)</p><p>Penicillin skin testing should be performed only by specifically trained personnel, usually allergy specialists, because any procedure that involves the deliberate exposure of a patient to a substance to which he/she may be allergic should be undertaken by someone with expertise in that technique.</p><p class="headingAnchor" id="H22604319"><span class="h2">Indications</span><span class="headingEndMark"> — </span>Skin testing is the most rapid, sensitive, and cost-effective testing modality for evaluating patients with immediate allergic reactions to penicillin and related drugs. It is recommended by the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fantibiotic-use%2Fcommunity%2Fpdfs%2Fpenicillin-factsheet.pdf&amp;token=8hQyJ8AVSlM%2FreJEP14loGoXrDoRq2dEoxr9ndmIs0vaTjELBVDOE1vvUYkYa5widgPQFAggPEGdWoYdnYPlfp504u4HLADtyceISu3JHhA%3D&amp;TOPIC_ID=16503" target="_blank">United States Centers for Disease Control and Prevention (CDC)</a> to reduce the unnecessary use of broad-spectrum antibiotics. Penicillin skin testing is the best method for detecting patients at risk for penicillin-induced anaphylaxis, because it is more sensitive than in vitro tests for penicillin-specific IgE [<a href="#rid1">1</a>]. (See  <a class="medical medical_review" href="/d/html/5541.html" rel="external">"Overview of skin testing for IgE-mediated allergic disease"</a>.)</p><p>Although the results are most likely to be positive in patients with immediate reactions, skin testing is also useful in excluding immediate reactions in patients with unclear histories of past penicillin reactions, such as isolated urticaria, isolated angioedema, or unspecified rash. Skin testing has no role in the diagnosis of blistering skin reactions, such as Stevens-Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN), or in reactions that are caused by other known mechanisms (eg, hemolytic anemia, interstitial nephritis).</p><p>Skin testing is ideally performed when the patient is well and not in urgent or immediate need of antibiotic therapy. The indications for penicillin skin testing are evolving, with a trend for testing more patients even if they have alternatives to penicillin or beta-lactam therapy. Penicillin skin testing was traditionally reserved for patients who required penicillins because there was no other suitable antibiotic [<a href="#rid2">2</a>], a situation that has become increasingly uncommon. However, alternative antibiotics are often less effective, more toxic, and/or more expensive than available penicillins. In addition, it is important to avoid unnecessary use of broad-spectrum antibiotics.</p><p class="headingAnchor" id="H668928"><span class="h2">Contraindications</span><span class="headingEndMark"> — </span>Contraindications to penicillin skin testing are similar to those for other forms of skin testing, which are mentioned briefly here and discussed in more detail separately (see  <a class="medical medical_review" href="/d/html/5541.html" rel="external">"Overview of skin testing for IgE-mediated allergic disease", section on 'Contraindications'</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Certain skin conditions (chronic urticaria, dermatographism) in which the skin is over-reactive and false-positive results may occur if not properly controlled for.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The inability to temporarily discontinue medications that either interfere with skin test interpretation or inhibit the clinician's ability to treat anaphylaxis should it occur as a result of testing (which is rare). (See <a class="local">'Patient preparation'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Severe blistering past reactions to penicillin, such as TEN, in which exposure to even minute amounts of the drug could cause recurrent symptoms.</p><p></p><p class="headingAnchor" id="H669643"><span class="h1">SAFETY</span></p><p class="headingAnchor" id="H426624412"><span class="h2">Overall</span><span class="headingEndMark"> — </span>Penicillin skin testing performed in the described manner rarely leads to systemic allergic reactions, although all allergy skin testing should take place in a setting prepared to treat possible allergic reactions, including anaphylaxis. Systemic allergic reactions are more likely with intradermal testing because more allergen is introduced into the skin. Fatal anaphylaxis in response to testing has not been reported since modern skin testing methods have been in use [<a href="#rid3">3-7</a>].</p><p class="headingAnchor" id="H1532771715"><span class="h2">Special populations</span></p><p class="headingAnchor" id="H982118311"><span class="h3">Pregnancy</span><span class="headingEndMark"> — </span>Skin testing can be safely performed in pregnant patients [<a href="#rid8">8,9</a>]. Historically, testing has been reserved for situations in which a penicillin is considered essential, such as the treatment of syphilis. (See  <a class="medical medical_review" href="/d/html/4794.html" rel="external">"Syphilis in pregnancy", section on 'Patients with immediate type allergic reactions to penicillin'</a>.) </p><p>However, the label of penicillin allergy can complicate prophylaxis for group B streptococcus (GBS) and antibiotic choice during peripartum surgeries and is associated with increased morbidity and hospital utilization [<a href="#rid10">10</a>]. As a result, there is interest in the safety of routine "delabeling" of pregnant patients with a history of penicillin reactions, particularly those classified as "low risk." In the largest study, 222 pregnant patients were referred by obstetricians for evaluation in an allergy clinic if they had penicillin reactions that occurred more than five years before, and either had features of IgE-mediated allergy or could not be characterized [<a href="#rid9">9</a>]. All patients underwent skin testing, and those with negative skin test results were challenged with 500 mg of oral <a class="drug drug_general" data-topicid="8673" href="/d/drug information/8673.html" rel="external">amoxicillin</a>. Overall, 94 percent had the label of penicillin allergic removed from their charts. The electronic medical record was retrospectively reviewed to determine how subsequent care of these patients differed from 141 similarly referred patients who did not follow up for allergy evaluation. Delabeled patients were more likely to receive penicillin (adjusted odds ratio [aOR] 18.0, 95% CI 6.3-51.2) and less likely to receive broad-spectrum alternatives (eg, <a class="drug drug_general" data-topicid="10037" href="/d/drug information/10037.html" rel="external">vancomycin</a>, <a class="drug drug_general" data-topicid="9275" href="/d/drug information/9275.html" rel="external">clindamycin</a>, and <a class="drug drug_general" data-topicid="8489" href="/d/drug information/8489.html" rel="external">gentamicin</a>) (aOR 0.29, 95% CI 0.17-0.50). Use of first-line prophylaxis for GBS (penicillin) and C-section (<a class="drug drug_general" data-topicid="9214" href="/d/drug information/9214.html" rel="external">cefazolin</a>) was also higher in patients who had been delabeled. These findings support the inclusion of referral and penicillin skin testing as an option for management of women with reported penicillin allergy in the American College of Obstetrics and Gynecology 2020 guidelines for prevention of GBS early-onset disease in newborns [<a href="#rid11">11,12</a>]. (See  <a class="medical medical_review" href="/d/html/438.html" rel="external">"Prevention of early-onset group B streptococcal disease in neonates", section on 'Antibiotic regimen'</a> and  <a class="medical medical_society_guidelines" href="/d/html/112235.html" rel="external">"Society guideline links: Group B streptococcal infection in pregnant women and neonates", section on 'United States'</a>.)</p><p class="headingAnchor" id="H2485585536"><span class="h3">Critical illness and immunosuppression</span><span class="headingEndMark"> — </span>Penicillin skin testing can also be performed safely and with accuracy in critically ill patients [<a href="#rid13">13-15</a>] and immunocompromised patients with cancer [<a href="#rid16">16-18</a>]. Antihistamines (H1 and H2) must be stopped for several days prior to skin testing, but glucocorticoids and most other immunosuppressant drugs do not generally interfere with immediate skin testing results. However, when performing skin testing in critically ill patients, it is important to ensure that the patient's skin is normally reactive to the positive histamine control. In a case control study, care in an intensive care unit during skin testing was associated with a high odds ratio for a negative histamine response [<a href="#rid19">19</a>]. The mechanism was not clear but it could be that critical illness itself and the psychotropic and neuromuscular blocking drugs used in this setting may dampen mast cells, making a negative histamine response more likely. (See  <a class="medical medical_review" href="/d/html/5541.html" rel="external">"Overview of skin testing for IgE-mediated allergic disease", section on 'Factors affecting results'</a>.)</p><p class="headingAnchor" id="H22604333"><span class="h1">PROCEDURE</span><span class="headingEndMark"> — </span>Penicillin skin testing results are obtained in less than one hour with minimal patient discomfort. Skin testing is valid in both adults and children [<a href="#rid20">20</a>]. The standard skin testing procedure involves two steps. Epicutaneous (prick-puncture) skin testing should be performed first and if negative, followed by intradermal (or intracutaneous) testing. In a study of 642 patients with delayed or unclear reaction histories, only intradermal penicillin skin testing (without prior prick testing) was performed, and no systemic reactions were observed. However, omission of prick testing warrants further research before becoming a standard of care [<a href="#rid21">21</a>].</p><p class="headingAnchor" id="H2466840"><span class="h2">Patient preparation</span><span class="headingEndMark"> — </span>The following factors should be considered when planning penicillin skin testing:</p><p class="bulletIndent1"><span class="glyph">●</span>Skin testing should not be performed in the weeks immediately following an episode of anaphylaxis, because during this type of severe allergic reaction, there is massive activation of mast cells, and the cells may then be hyporeactive for a period of time, leading to possible false-negative results. It is customary to allow a period of at least four weeks to elapse after anaphylaxis before any skin testing is performed. (See  <a class="medical medical_review" href="/d/html/5541.html" rel="external">"Overview of skin testing for IgE-mediated allergic disease", section on 'Recent anaphylaxis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The patient's medications should be reviewed.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Any medications that could interfere with the results of skin testing (eg, antihistamines) should be temporarily discontinued, if possible. The duration that various medications should be withheld is reviewed separately. (See  <a class="medical medical_review" href="/d/html/5541.html" rel="external">"Overview of skin testing for IgE-mediated allergic disease", section on 'Medications that should be discontinued'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Any medications that could interfere with the ability to treat anaphylaxis should be noted (eg, beta-blockers, angiotensin-converting enzyme [ACE] inhibitors). If possible, these medications may be held temporarily (particularly in patients with extremely severe reaction histories) or this may not be necessary since most patients are very unlikely to develop anaphylaxis as a result of skin testing. (See  <a class="medical medical_review" href="/d/html/5541.html" rel="external">"Overview of skin testing for IgE-mediated allergic disease", section on 'Beta blockers and ACE inhibitors'</a>.)</p><p></p><p class="headingAnchor" id="H27040356"><span class="h2">Skin testing reagents and concentrations</span><span class="headingEndMark"> — </span>Most penicillin-allergic patients are not allergic to the intact penicillin molecule. The majority of patients are allergic to degradation products of penicillin covalently linked to self-proteins. Thus, skin testing with a simple solution of the drug as it is normally administered is not adequate to identify allergy in most patients. Insight into the immunochemistry of penicillin allowed for the development of skin testing reagents to detect penicillin-specific IgE antibodies (<a class="graphic graphic_figure graphicRef67647" href="/d/graphic/67647.html" rel="external">figure 1</a>).</p><p>Penicillin skin testing is usually performed with the following reagents (<a class="graphic graphic_table graphicRef58347" href="/d/graphic/58347.html" rel="external">table 3</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>The major determinant:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_general" data-topicid="15949" href="/d/drug information/15949.html" rel="external">Penicilloyl-polylysine</a> (PPL) (Pre-Pen) (6 x 10<sup>-5</sup> M). Penicilloyl-polylysine is also known as benzylpenicilloyl-polylysine. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The minor determinants:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_general" data-topicid="9749" href="/d/drug information/9749.html" rel="external">Penicillin G</a> (10,000 units/mL)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Penicilloate (if available) (0.01 M)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Penilloate (if available) (0.01 M)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="8737" href="/d/drug information/8737.html" rel="external">Ampicillin</a> and or <a class="drug drug_general" data-topicid="8673" href="/d/drug information/8673.html" rel="external">amoxicillin</a> (3 to 25 mg/mL) if relevant to the patient's care</p><p></p><p>The minimal reagents required are positive and negative controls, the major determinant (PPL) and the minor determinant <a class="drug drug_general" data-topicid="9749" href="/d/drug information/9749.html" rel="external">penicillin G</a>. The minor determinant mixture (MDM) is included, if available, and the aminopenicillins are included if the patient reacted to these drugs or may need them in the future.</p><p>In the rare patient with a history of exquisite penicillin sensitivity (eg, a nurse who reacts to airborne penicillin), initial skin testing reagents may be diluted beyond the standard concentrations.</p><p>Penicillin intradermal skin testing involves raising a 2 to 3 mm bleb in the skin with each of the test solutions. (See  <a class="medical medical_review" href="/d/html/5541.html" rel="external">"Overview of skin testing for IgE-mediated allergic disease", section on 'Intradermal method'</a>.)</p><p>Each test solution may be applied in duplicate (as stated in the Pre-Pen package insert) or singly. The recommendation to test in duplicate comes from a single large study in which 7 percent of duplicate tests were discordant [<a href="#rid4">4</a>]. If a single intradermal test result is equivocal, it should be repeated in duplicate.</p><p>The package insert for <a class="drug drug_general" data-topicid="9749" href="/d/drug information/9749.html" rel="external">penicillin G</a> potassium states that after reconstitution of the vial from the powder form, the full-strength solution (eg, 1 million units/mL) can be stored and used for one week if refrigerated. Published data about the impact of longer-term storage on penicillin solutions for use in skin testing are not available, and this practice is discouraged.</p><p class="headingAnchor" id="H669689"><span class="h3">Controls</span><span class="headingEndMark"> — </span>Both a positive control of histamine (10 mg/mL as histamine dichloride; 6.6 mg/mL as histamine base, for epicutaneous use) and a negative intradermal control of diluent identical to that of the allergen extracts (usually glycerinated <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a>) should always be applied in order to verify that the patient's skin is normally responsive.</p><p class="headingAnchor" id="H22605965"><span class="h3">Major determinant</span><span class="headingEndMark"> — </span>The majority of penicillin antigens arise from degradation to the penicilloyl determinant following administration. Penicilloyl is the major determinant, and when complexed to polylysine, it constitutes a multivalent skin test reagent known as PPL. PPL is important for reliable skin testing, as up to 75 percent of penicillin skin test-positive patients react only to PPL, depending on the population studied [<a href="#rid4">4,22,23</a>]. Hence, skin testing without PPL may fail to identify many penicillin-allergic individuals and is not recommended.</p><p>Of note, the percentage of patients reacting only to PPL appears to be lower in European populations compared with North American patients [<a href="#rid24">24</a>]. One potential explanation for this is the higher prevalence of patients selectively allergic to <a class="drug drug_general" data-topicid="8673" href="/d/drug information/8673.html" rel="external">amoxicillin</a>/<a class="drug drug_general" data-topicid="8737" href="/d/drug information/8737.html" rel="external">ampicillin</a> in Europe. Despite geographic and perhaps temporal differences in the prevalence of unique PPL sensitivity, use of PPL in penicillin skin testing is essential to maximize clinical sensitivity.</p><p>PPL is commercially available as Pre-Pen. This product was not available in the United States for approximately five years, but its production was resumed in late 2009. Other products may be available in different countries [<a href="#rid25">25</a>]. Pre-Pen<sup> </sup>contains PPL at a single concentration of penicilloyl and is applied to the skin undiluted for both prick and intradermal testing. Diluted solutions may be used initially for the rare patient whose history suggests exquisite sensitivity.</p><p class="headingAnchor" id="H22605972"><span class="h3">Minor determinants</span><span class="headingEndMark"> — </span>The minor penicillin antigenic determinants are benzylpenicillin (<a class="drug drug_general" data-topicid="9749" href="/d/drug information/9749.html" rel="external">penicillin G</a>), benzylpenicilloate, and benzylpenilloate. Of these, only penicillin G is available commercially.</p><p>Standard intravenous preparations of benzylpenicillin (<a class="drug drug_general" data-topicid="9749" href="/d/drug information/9749.html" rel="external">penicillin G</a>) may be used for skin testing at a concentration of 10,000 units/mL (<a class="graphic graphic_table graphicRef58347" href="/d/graphic/58347.html" rel="external">table 3</a>).</p><p>Benzylpenicilloate and benzylpenilloate (also known as MDM) are not commercially available (except for a product available in Spain and South America), but the importance of these reagents is controversial. In large scale studies, about 10 percent of penicillin skin test-positive patients are positive only to penicilloate and/or penilloate [<a href="#rid4">4,22,23,25-30</a>]. One small study suggested that patients who tested positive only to the MDMs were at higher risk for severe allergic reactions. However, larger studies found that the negative predictive value of skin testing with PPL plus MDM was similar to that of PPL plus benzylpenicillin alone [<a href="#rid5">5,13,31-33</a>]. Stated differently, although patients exist who only test positive to MDM, challenges of patients skin test-negative to PPL and benzylpenicillin had similar reaction rates compared with patients skin test-negative to the full set of major and minor penicillin determinants [<a href="#rid4">4,27,34</a>]. However, these studies had insufficient power to detect a small difference in rates. Thus, the presumed clinical value of the MDM as a skin testing reagent compared with benzylpenicillin alone is based on the observation that a few more patients with positive skin tests will be detected using the full skin test battery (<a class="graphic graphic_table graphicRef58347" href="/d/graphic/58347.html" rel="external">table 3</a>).</p><p>Although the recommended approach is to include PPL in skin testing of all patients, one study retrospectively evaluated the utility of testing with only the minor determinant <a class="drug drug_general" data-topicid="9749" href="/d/drug information/9749.html" rel="external">penicillin G</a> during a three-year period when PPL was not commercially available [<a href="#rid35">35</a>]. The study population consisted of children with past allergic reactions (immediate or nonsevere-delayed) to any penicillin drug (including <a class="drug drug_general" data-topicid="8673" href="/d/drug information/8673.html" rel="external">amoxicillin</a> and <a class="drug drug_general" data-topicid="8737" href="/d/drug information/8737.html" rel="external">ampicillin</a>), of whom 89 percent had reacted to amoxicillin. They were tested with benzylpenicillin (penicillin G), and if negative, challenged with a three-step protocol using the penicillin that caused the original reaction (ie, amoxicillin in most cases). Positive skin test results were obtained in 33 percent, which is much higher than in most studies, and those children were not challenged. Of the 378 children with negative skin test results, all but three were challenged, and 18 reacted (4.8 percent), yielding a negative predictive value for testing with penicillin G alone of 95 percent in that population (95% CI, 93-97 percent). However, these findings are different from those of many previous studies and require confirmation in other populations before the importance of PPL is questioned.</p><p class="headingAnchor" id="H22605979"><span class="h3">Aminopenicillins</span><span class="headingEndMark"> — </span>Aminopenicillins, such as <a class="drug drug_general" data-topicid="8673" href="/d/drug information/8673.html" rel="external">amoxicillin</a> and <a class="drug drug_general" data-topicid="8737" href="/d/drug information/8737.html" rel="external">ampicillin</a>, should be included in the skin testing panel for any patient who reports an immediate systemic reaction to these drugs. Patients who are selectively allergic to the aminopenicillins form IgE antibodies which recognize, at least in part, the side R-group side chain rather than the core penicilloyl determinant [<a href="#rid34">34,36-39</a>]. These individuals react only to amoxicillin or ampicillin on skin testing and are negative to PPL, benzylpenicillin, and MDM. The importance of the MDM in diagnosing selective allergy to the aminopenicillins is not clear for the reasons discussed previously.</p><p>Concentrations ranging from 3 to 25 mg/mL of aminopenicillins have been reported to be nonirritating and may be used for skin testing (<a class="graphic graphic_table graphicRef58347" href="/d/graphic/58347.html" rel="external">table 3</a>) [<a href="#rid22">22,37,40-42</a>]. In the author's clinic, the following are used:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Amoxicillin</strong> – 3 mg/mL (prepared via a compounding pharmacy from bulk <a class="drug drug_general" data-topicid="8673" href="/d/drug information/8673.html" rel="external">amoxicillin</a> available as sodium salt of the pure acid) [<a href="#rid43">43</a>].</p><p></p><p class="bulletIndent1">In Europe, higher concentrations of <a class="drug drug_general" data-topicid="8673" href="/d/drug information/8673.html" rel="external">amoxicillin</a> have been used, and these require that the sodium salt is used and also require a higher pH in order to maintain solubility [<a href="#rid44">44</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ampicillin</strong> – Vials containing 250 mg, 500 mg, 1 g, and 2 g <a class="drug drug_general" data-topicid="8737" href="/d/drug information/8737.html" rel="external">ampicillin</a> sterile powder for parenteral administration may be reconstituted with an appropriate volume of sterile water to provide a solution of appropriate concentration. The author's approach is to make a 250 mg/mL solution initially and then dilute it 20-fold to yield a concentration of 12.5 mg/mL for skin testing. If reconstituted under correct conditions and refrigerated, it will maintain potency and can be used for skin testing for up to 72 hours.</p><p></p><p>If a solution of <a class="drug drug_general" data-topicid="8673" href="/d/drug information/8673.html" rel="external">amoxicillin</a> is not readily available, the clinician could skin test to PPL, benzylpenicillin, and MDM (if available), as well as <a class="drug drug_general" data-topicid="8737" href="/d/drug information/8737.html" rel="external">ampicillin</a> at the concentrations discussed previously. This approach will detect the majority of patients who are allergic to amoxicillin. However, the clinician should be aware that it is possible to be selectively allergic to amoxicillin and not ampicillin (and vice versa), since the structures are similar but not identical. Therefore, if skin tests with ampicillin and other penicillin reagents are negative and the patient is to undergo graded challenge with amoxicillin to exclude immediate allergy, appropriate precautions should be taken if the patient's past reaction was more significant than urticaria/angioedema.</p><p class="headingAnchor" id="H667452"><span class="h3">Clavulanate testing in patient reactive to amoxicillin-clavulanate</span><span class="headingEndMark"> — </span>Patients who reacted to the combination of <a class="drug drug_general" data-topicid="8676" href="/d/drug information/8676.html" rel="external">amoxicillin-clavulanate</a> may be allergic to clavulanate, although this is uncommon [<a href="#rid45">45,46</a>]. Clavulanate allergy should be considered in a patient who reacted to the combination of amoxicillin-clavulanate but has negative skin tests to penicillin and <a class="drug drug_general" data-topicid="8673" href="/d/drug information/8673.html" rel="external">amoxicillin</a> reagents. Although skin testing to clavulanate alone (20 mg/mL) is more sensitive than testing with the combination of amoxicillin and clavulanate, obtaining clavulanate for testing is extremely difficult outside of certain areas, such as Europe, where clavulanate is commercially available as a testing reagent.</p><p class="headingAnchor" id="H22604340"><span class="h1">INTERPRETATION OF RESULTS</span><span class="headingEndMark"> — </span>A positive reaction consists of a central area of superficial skin edema (wheal) surrounded by erythema (flare). The site is usually pruritic. This reaction represents the immediate phase of the allergic reaction. If the patient's cutaneous mast cells are not activated, then no edema or erythema develops, and the test is negative. Falsely-negative skin tests can result when patients have received medications, such as antihistamines, that block the skin effects of immediate mast cell mediators. (See <a class="local">'Patient preparation'</a> above.)</p><p>Prick-puncture skin testing results are read 15 minutes after application:</p><p class="bulletIndent1"><span class="glyph">●</span>A positive response is a wheal that is 3 mm or greater in mean diameter than the negative control.</p><p class="bulletIndent1"><span class="glyph">●</span>A negative response is no reaction at the prick site or erythema alone without a wheal.</p><p></p><p>Intradermal skin testing is read 15 to 20 minutes after application:</p><p class="bulletIndent1"><span class="glyph">●</span>A positive response is a wheal that has increased in size from the original bleb and is 3 mm or greater in mean diameter than the negative control.</p><p class="bulletIndent1"><span class="glyph">●</span>A negative response is no increase in the size of the original bleb and no wheal greater than the control site.</p><p></p><p class="headingAnchor" id="H22604347"><span class="h2">Positive predictive value</span><span class="headingEndMark"> — </span>Data on the positive predictive value of penicillin skin testing are limited due to ethical concerns of challenging skin test-positive patients with penicillin. In addition, drug-specific IgE is believed to be a necessary but not always sufficient factor for a symptomatic drug reaction. A 2019 systematic review of the published literature found the positive predictive value of penicillin skin testing, in well-characterized patients, to be 83 percent [<a href="#rid47">47</a>]. If studies with imprecise methodology are included, the positive predictive value ranged from 10 to 100 percent, but most studies report a value over 50 percent. [<a href="#rid5">5,21,27,28,34,48-52</a>]. Even these lower rates are comparable with that observed in Hymenoptera allergy skin testing [<a href="#rid53">53</a>]. </p><p>Patients who test positive to penicillin should avoid all penicillins (ie, including the aminopenicillins and newer semisynthetic penicillins). (See  <a class="medical medical_review" href="/d/html/2073.html" rel="external">"Penicillin allergy: Immediate reactions", section on 'Options for future treatment'</a>.)</p><p class="headingAnchor" id="H22604354"><span class="h2">Negative predictive value</span><span class="headingEndMark"> — </span>The negative predictive value of penicillin skin testing when performed with the major determinant plus <a class="drug drug_general" data-topicid="9749" href="/d/drug information/9749.html" rel="external">penicillin G</a> (or a full MDM panel) is very high. Serious immediate reactions in patients challenged with penicillin following negative penicillin skin testing have not been reported. In large scale studies, 1 to 3 percent of penicillin skin test-negative patients (ie, when tested with the major determinant plus penicillin G [or a full MDM panel]) developed mild, usually self-limiting reactions upon being challenged with the drug [<a href="#rid4">4,7,13,27,33,48,54-57</a>].</p><p>The clinical importance of including the MDM in skin testing is controversial, since the negative predictive value of skin testing with only PPL and benzylpenicillin is comparable with testing with all the reagents [<a href="#rid4">4,5,13,27,31-34</a>]. The best available estimate is that at least another 10 percent of penicillin-sensitized patients can be identified by using the full panel of MDM reagents (ie, <a class="drug drug_general" data-topicid="9749" href="/d/drug information/9749.html" rel="external">penicillin G</a>, benzylpenicilloate, and benzylpenilloate). Skin testing with the minor determinant penicillin G alone is not the recommended approach. (See <a class="local">'Minor determinants'</a> above.)</p><p>Skin testing with the aminopenicillins is not as well-studied, and very few data are available on the predictive value. There is an impression from the Spanish experience that the negative predictive value is not as high as that of the benzylpenicillin determinants, but this has not been demonstrated conclusively.</p><p class="headingAnchor" id="H2468787"><span class="h1">CONFIRMATORY CHALLENGE AFTER NEGATIVE SKIN TESTING</span><span class="headingEndMark"> — </span>In a patient with negative skin test results, the absence of allergy should be confirmed by administering an age-appropriate dose of the penicillin to which the patient initially reacted, followed by one to two hours of observation to ensure that an immediate reaction does not occur. Challenge is indicated because the negative predictive value for penicillin skin testing with the combination of PPL and <a class="drug drug_general" data-topicid="9749" href="/d/drug information/9749.html" rel="external">penicillin G</a> is very high, but not 100 percent. Also, confirming that the drug is tolerated will maximize the comfort of the patient and other clinicians with using penicillins in the future [<a href="#rid58">58</a>].</p><p>It is best to challenge the patient with the specific penicillin to which he/she reacted, when possible. The following examples are illustrative:</p><p class="bulletIndent1"><span class="glyph">●</span>In a patient who reacted to <a class="drug drug_general" data-topicid="8673" href="/d/drug information/8673.html" rel="external">amoxicillin</a>, challenging with amoxicillin ensures that the patient is not selectively allergic to amoxicillin. The negative predictive value of penicillin skin testing in patients primarily allergic to aminopenicillins is not well-defined. Challenge with amoxicillin will detect allergy to amoxicillin or penicillin, whereas challenge with penicillin would only identify penicillin allergy.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a patient who reacted to <a class="drug drug_general" data-topicid="8676" href="/d/drug information/8676.html" rel="external">amoxicillin-clavulanate</a>, challenge with the combination can help identify clavulanate allergy if both penicillin and <a class="drug drug_general" data-topicid="8673" href="/d/drug information/8673.html" rel="external">amoxicillin</a> skin tests were negative but clavulanate was not available for testing.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For testing of inpatients with a current need for a particular penicillin product, the challenge procedure can be incorporated into the first parenteral dose by administering 1/10<sup>th</sup> of a normal dose, observing for one hour, then if there is no adverse reaction, administering the remaining 9/10<sup>th</sup> of the dose and observing for another hour. Patients who tolerate this type of challenge prove that they are not allergic and can receive additional doses normally.</p><p></p><p class="headingAnchor" id="H3599422732"><span class="h1">UPDATING THE PATIENT'S RECORDS</span><span class="headingEndMark"> — </span>For a patient with negative penicillin skin testing who has passed a confirmatory challenge, the final step is to update the patient's medical record and also make sure that the patient, the primary care provider (PCP), and the patient's pharmacy all understand that the label of penicillin allergy should be removed. The importance of these final steps was illustrated by a study in which 100 children who had tested negative for penicillin allergy after an initial reaction were followed up after an average of one year [<a href="#rid59">59</a>]. Phone surveys with the parent/caregiver and with the PCP revealed that 90 percent of parents understood the results of the previous testing, and 80 percent had informed their child's PCP as instructed. However, 84 percent of PCPs did not recall being notified, and 52 percent of the children's medical records from the PCP's office still listed the penicillin allergy as active. However, despite this imperfect communication, 36 children had been treated with penicillin or its derivatives, and just one child had developed a delayed exanthem. This study supports previous findings in adults, in which improving communication with the entire health care team enhanced the effectiveness of penicillin allergy label removal [<a href="#rid60">60</a>].</p><p>In addition to clearly explaining to the patient/caregiver that the patient can now safely take penicillins, the allergist should explain that negative skin testing (and single-dose challenge) does not mean that the patient will not get a delayed reaction, and it also does not exclude the possibility of future sensitization. However, the risk is comparable with that in the general population. Information for patients about this is provided. (See <a class="local">'Information for patients'</a> below.)</p><p class="headingAnchor" id="H346228419"><span class="h1">RESENSITIZATION</span><span class="headingEndMark"> — </span>Based on available data, resensitization appears to occur in 0 to 3 percent of patients after a course of an oral penicillin and up to 20 percent after a course of a parenteral penicillin. However, resensitization does not predict clinical reactivity. The clinical implications of this must be weighed in the context of the severity of the patient's initial reaction.</p><p>Several studies have examined rates of resensitization, or the redevelopment of penicillin-specific IgE, in patients who had lost their sensitivity. Resensitization may be determined by the number of patients who convert their penicillin skin tests from negative (before the challenge) to positive (after the challenge). However, this method does not predict which patients will actually react, because sensitization does not predict actual allergy precisely. Another way to assess the risk of recurrence is to determine the number of patients with a history of penicillin allergy who tolerate <strong>two or more</strong> courses of penicillins, who can therefore be assumed to not have been resensitized by the initial course.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Following oral administration</strong> – Using the methods just described, most studies of penicillin resensitization after oral challenge or after a single course of an oral penicillin or <a class="drug drug_general" data-topicid="8673" href="/d/drug information/8673.html" rel="external">amoxicillin</a> showed resensitization rates between 0 and 3 percent [<a href="#rid54">54,56,61-63</a>], which are comparable with the rate of primary sensitization. Another study evaluated resensitization after repeated courses of oral penicillin in 53 adult patients [<a href="#rid62">62</a>]. Patients with a convincing history of penicillin allergy and initially negative penicillin skin tests were challenged with three consecutive <a class="drug drug_general" data-topicid="9751" href="/d/drug information/9751.html" rel="external">penicillin V</a> courses and underwent three repeat penicillin skin tests. None converted to a positive skin test during this process [<a href="#rid62">62</a>]. Based on these data, it is not routinely necessary to repeat skin testing in a patient with past penicillin reactions who has tolerated a subsequent course of oral penicillin. Similarly, if penicillin skin testing is not available and patients with a history of penicillin allergy are given and tolerate penicillin via graded challenge, no special precautions are required for future penicillin treatment courses.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Following intravenous or intramuscular administration</strong> – Early studies of resensitization following parenteral administration of penicillin reported that it may be more common (rates of 5 to 20 percent) [<a href="#rid64">64,65</a>]. However, more recent research has contradicted those data, finding rates of 0 percent [<a href="#rid66">66</a>]. Therefore, repeat skin testing (or cautious administration of penicillins if skin testing is not available) is not routinely necessary for patients with a history of penicillin allergy who have tolerated a parenteral course of penicillin. Consideration may be given to retesting individuals with recent or particularly severe previous reactions.</p><p></p><p class="headingAnchor" id="H3210217298"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/109237.html" rel="external">"Society guideline links: Drug allergy and hypersensitivity"</a>.)</p><p class="headingAnchor" id="H3027657386"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/d/html/97406.html" rel="external">"Patient education: Significance of negative penicillin allergy skin testing (Beyond the Basics)"</a> and  <a class="medical medical_patient" href="/d/html/367.html" rel="external">"Patient education: Allergy to penicillin and related antibiotics (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H22605986"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Mechanism of skin testing</strong> – Allergen skin testing is a bioassay that detects the presence of allergen-specific immunoglobulin (Ig)E on a patient's mast cells. Patients with detectable penicillin-specific IgE on their mast cells are said to be "sensitized" to penicillin and are at high risk for an immediate allergic reaction to the drug. Skin testing is the most rapid, sensitive, and cost-effective testing modality for identifying penicillin-sensitized patients. (See <a class="local">'Immediate penicillin reactions'</a> above and <a class="local">'Mechanism of skin testing'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Safety and referral</strong> – Penicillin skin testing is a safe procedure, although it should be performed by allergy experts when possible, since they have the training to interpret the results accurately and the experience, staff, and equipment to treat possible (albeit rare) allergic reactions. (See <a class="local">'Referral'</a> above and <a class="local">'Safety'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Procedure</strong> – Epicutaneous (prick-puncture) skin testing should be performed first, and if negative, intradermal tests should follow. The minimal reagents required are positive and negative controls, the major determinant (<a class="drug drug_general" data-topicid="15949" href="/d/drug information/15949.html" rel="external">penicilloyl-polylysine</a> [PPL]) and the minor determinant <a class="drug drug_general" data-topicid="9749" href="/d/drug information/9749.html" rel="external">penicillin G</a> (<a class="graphic graphic_table graphicRef58347" href="/d/graphic/58347.html" rel="external">table 3</a>). The minor determinant mixture (MDM) is included if available, and the aminopenicillins are included if the patient reacted to these drugs or may need them in the future. (See <a class="local">'Procedure'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Positive and negative predictive values</strong> – The positive predictive value of penicillin skin testing performed in this manner is approximately 50 percent, which is similar to that of skin testing with many other allergens. The negative predictive value is very high (ie, 97 to 99 percent), although it may be lower for <a class="drug drug_general" data-topicid="8673" href="/d/drug information/8673.html" rel="external">amoxicillin</a> and <a class="drug drug_general" data-topicid="8737" href="/d/drug information/8737.html" rel="external">ampicillin</a>. (See <a class="local">'Interpretation of results'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Confirmatory challenge after negative skin testing</strong> – Following negative skin test results, the absence of allergy should be confirmed with a drug challenge (usually oral). A dose of the penicillin to which the patient reacted in the past is administered, and the patient is observed for one to two hours to ensure that an immediate reaction does not occur. (See <a class="local">'Confirmatory challenge after negative skin testing'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Sousa-Pinto B, Tarrio I, Blumenthal KG, et al. Accuracy of penicillin allergy diagnostic tests: A systematic review and meta-analysis. J Allergy Clin Immunol 2021; 147:296.</a></li><li><a class="nounderline abstract_t">Joint Task Force on Practice Parameters, American Academy of Allergy, Asthma and Immunology, American College of Allergy, Asthma and Immunology, Joint Council of Allergy, Asthma and Immunology. Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol 2010; 105:259.</a></li><li><a class="nounderline abstract_t">Park M, Markus P, Matesic D, Li JT. Safety and effectiveness of a preoperative allergy clinic in decreasing vancomycin use in patients with a history of penicillin allergy. Ann Allergy Asthma Immunol 2006; 97:681.</a></li><li><a class="nounderline abstract_t">Gadde J, Spence M, Wheeler B, Adkinson NF Jr. Clinical experience with penicillin skin testing in a large inner-city STD clinic. JAMA 1993; 270:2456.</a></li><li><a class="nounderline abstract_t">Green GR, Rosenblum AH, Sweet LC. Evaluation of penicillin hypersensitivity: value of clinical history and skin testing with penicilloyl-polylysine and penicillin G. A cooperative prospective study of the penicillin study group of the American Academy of Allergy. J Allergy Clin Immunol 1977; 60:339.</a></li><li><a class="nounderline abstract_t">Valyasevi MA, Van Dellen RG. Frequency of systematic reactions to penicillin skin tests. Ann Allergy Asthma Immunol 2000; 85:363.</a></li><li><a class="nounderline abstract_t">Sullivan TJ, Wedner HJ, Shatz GS, et al. Skin testing to detect penicillin allergy. J Allergy Clin Immunol 1981; 68:171.</a></li><li><a class="nounderline abstract_t">Macy E. Penicillin skin testing in pregnant women with a history of penicillin allergy and group B streptococcus colonization. Ann Allergy Asthma Immunol 2006; 97:164.</a></li><li><a class="nounderline abstract_t">Wolfson AR, Mancini CM, Banerji A, et al. Penicillin Allergy Assessment in Pregnancy: Safety and Impact on Antibiotic Use. J Allergy Clin Immunol Pract 2021; 9:1338.</a></li><li><a class="nounderline abstract_t">Desai SH, Kaplan MS, Chen Q, Macy EM. Morbidity in Pregnant Women Associated with Unverified Penicillin Allergies, Antibiotic Use, and Group B Streptococcus Infections. Perm J 2017; 21:16.</a></li><li><a class="nounderline abstract_t">Prevention of Group B Streptococcal Early-Onset Disease in Newborns: ACOG Committee Opinion, Number 797. Obstet Gynecol 2020; 135:e51.</a></li><li><a class="nounderline abstract_t">Committee Opinion No. 797: Prevention of Group B Streptococcal Early-Onset Disease in Newborns: Correction. Obstet Gynecol 2020; 135:978. Reaffirmed 2022.</a></li><li><a class="nounderline abstract_t">del Real GA, Rose ME, Ramirez-Atamoros MT, et al. Penicillin skin testing in patients with a history of beta-lactam allergy. Ann Allergy Asthma Immunol 2007; 98:355.</a></li><li><a class="nounderline abstract_t">Arroliga ME, Radojicic C, Gordon SM, et al. A prospective observational study of the effect of penicillin skin testing on antibiotic use in the intensive care unit. Infect Control Hosp Epidemiol 2003; 24:347.</a></li><li><a class="nounderline abstract_t">Rimawi RH, Mazer MA. Expanding the pool of healthcare providers to perform penicillin skin testing in the ICU. Intensive Care Med 2014; 40:462.</a></li><li><a class="nounderline abstract_t">Taremi M, Artau A, Foolad F, et al. Safety, Efficacy, and Clinical Impact of Penicillin Skin Testing in Immunocompromised Cancer Patients. J Allergy Clin Immunol Pract 2019; 7:2185.</a></li><li><a class="nounderline abstract_t">Trubiano JA, Thursky KA, Stewardson AJ, et al. Impact of an Integrated Antibiotic Allergy Testing Program on Antimicrobial Stewardship: A Multicenter Evaluation. Clin Infect Dis 2017; 65:166.</a></li><li><a class="nounderline abstract_t">Trubiano JA, Grayson ML, Phillips EJ, et al. Antibiotic allergy testing improves antibiotic appropriateness in patients with cancer. J Antimicrob Chemother 2018; 73:3209.</a></li><li><a class="nounderline abstract_t">Geng B, Thakor A, Clayton E, et al. Factors associated with negative histamine control for penicillin allergy skin testing in the inpatient setting. Ann Allergy Asthma Immunol 2015; 115:33.</a></li><li><a class="nounderline abstract_t">Fox SJ, Park MA. Penicillin skin testing is a safe and effective tool for evaluating penicillin allergy in the pediatric population. J Allergy Clin Immunol Pract 2014; 2:439.</a></li><li><a class="nounderline abstract_t">Confino-Cohen R, Rosman Y, Meir-Shafrir K, et al. Oral Challenge without Skin Testing Safely Excludes Clinically Significant Delayed-Onset Penicillin Hypersensitivity. J Allergy Clin Immunol Pract 2017; 5:669.</a></li><li><a class="nounderline abstract_t">Macy E, Richter PK, Falkoff R, Zeiger R. Skin testing with penicilloate and penilloate prepared by an improved method: amoxicillin oral challenge in patients with negative skin test responses to penicillin reagents. J Allergy Clin Immunol 1997; 100:586.</a></li><li><a class="nounderline abstract_t">Bousquet PJ, Co-Minh HB, Arnoux B, et al. Importance of mixture of minor determinants and benzylpenicilloyl poly-L-lysine skin testing in the diagnosis of beta-lactam allergy. J Allergy Clin Immunol 2005; 115:1314.</a></li><li><a class="nounderline abstract_t">Bousquet PJ, Pipet A, Bousquet-Rouanet L, Demoly P. Oral challenges are needed in the diagnosis of beta-lactam hypersensitivity. Clin Exp Allergy 2008; 38:185.</a></li><li><a class="nounderline abstract_t">Matheu V, Pérez E, González R, et al. Assessment of a new brand of determinants for skin testing in a large group of patients with suspected beta-lactam allergy. J Investig Allergol Clin Immunol 2007; 17:257.</a></li><li class="breakAll">Adkinson NF, personal communication.</li><li><a class="nounderline abstract_t">Sogn DD, Evans R 3rd, Shepherd GM, et al. Results of the National Institute of Allergy and Infectious Diseases Collaborative Clinical Trial to test the predictive value of skin testing with major and minor penicillin derivatives in hospitalized adults. Arch Intern Med 1992; 152:1025.</a></li><li><a class="nounderline abstract_t">Macy E, Burchette RJ. Oral antibiotic adverse reactions after penicillin skin testing: multi-year follow-up. Allergy 2002; 57:1151.</a></li><li><a class="nounderline abstract_t">Jost BC, Wedner HJ, Bloomberg GR. Elective penicillin skin testing in a pediatric outpatient setting. Ann Allergy Asthma Immunol 2006; 97:807.</a></li><li><a class="nounderline abstract_t">Park MA, Matesic D, Markus PJ, Li JT. Female sex as a risk factor for penicillin allergy. Ann Allergy Asthma Immunol 2007; 99:54.</a></li><li><a class="nounderline abstract_t">BROWN BC, PRICE EV, MOORE MB Jr. PENICILLOYL-POLYLYSINE AS AN INTRADERMAL TEST OF PENICILLIN SENSITIVITY. JAMA 1964; 189:599.</a></li><li><a class="nounderline abstract_t">Shepherd G. Clinical experience using only PrePen and penicillin G to detect penicillin allergy in hospitalized patients. J Allergy Clin Immunol 1997; 99:S134 (Abstract).</a></li><li><a class="nounderline abstract_t">Macy E, Ngor EW. Safely diagnosing clinically significant penicillin allergy using only penicilloyl-poly-lysine, penicillin, and oral amoxicillin. J Allergy Clin Immunol Pract 2013; 1:258.</a></li><li><a class="nounderline abstract_t">Solley GO, Gleich GJ, Van Dellen RG. Penicillin allergy: clinical experience with a battery of skin-test reagents. J Allergy Clin Immunol 1982; 69:238.</a></li><li><a class="nounderline abstract_t">Picard M, Paradis L, Bégin P, et al. Skin testing only with penicillin G in children with a history of penicillin allergy. Ann Allergy Asthma Immunol 2014; 113:75.</a></li><li><a class="nounderline abstract_t">Moss RB. Drug allergy in cystic fibrosis. Clin Rev Allergy 1991; 9:211.</a></li><li><a class="nounderline abstract_t">Blanca M, Vega JM, Garcia J, et al. Allergy to penicillin with good tolerance to other penicillins; study of the incidence in subjects allergic to beta-lactams. Clin Exp Allergy 1990; 20:475.</a></li><li><a class="nounderline abstract_t">Vega JM, Blanca M, García JJ, et al. Immediate allergic reactions to amoxicillin. Allergy 1994; 49:317.</a></li><li><a class="nounderline abstract_t">Blanca M, Perez E, Garcia J, et al. Anaphylaxis to amoxycillin but good tolerance for benzyl penicillin. In vivo and in vitro studies of specific IgE antibodies. Allergy 1988; 43:508.</a></li><li><a class="nounderline abstract_t">Miranda A, Blanca M, Vega JM, et al. Cross-reactivity between a penicillin and a cephalosporin with the same side chain. J Allergy Clin Immunol 1996; 98:671.</a></li><li><a class="nounderline abstract_t">Marcos Bravo C, Luna Ortiz I, González Vázquez R. Hypersensitivity to cefuroxime with good tolerance to other betalactams. Allergy 1995; 50:359.</a></li><li><a class="nounderline abstract_t">Sastre J, Quijano LD, Novalbos A, et al. Clinical cross-reactivity between amoxicillin and cephadroxil in patients allergic to amoxicillin and with good tolerance of penicillin. Allergy 1996; 51:383.</a></li><li class="breakAll">Amoxicillin is available from Sigma-Aldrich, St Louis, MO (product number A 8523). This preparation is not intended for human administration, and use in skin testing may require IRB approval at some centers. www.sigmaldrich.com (Accessed on October 10, 2011).</li><li><a class="nounderline abstract_t">Montañez MI, Torres MJ, Perez-Inestrosa E, Blanca M. Clarification concerning amoxicillin skin testing. J Allergy Clin Immunol 2011; 128:685; author reply 686.</a></li><li><a class="nounderline abstract_t">Fernandez-Rivas M, Perez Carral C, Cuevas M, et al. Selective allergic reactions to clavulanic acid. J Allergy Clin Immunol 1995; 95:748.</a></li><li><a class="nounderline abstract_t">Torres MJ, Ariza A, Mayorga C, et al. Clavulanic acid can be the component in amoxicillin-clavulanic acid responsible for immediate hypersensitivity reactions. J Allergy Clin Immunol 2010; 125:502.</a></li><li><a class="nounderline abstract_t">Chiriac AM, Vasconcelos MJ, Izquierdo L, et al. To challenge or not to challenge: Literature data on the positive predictive value of skin tests to beta-lactams. J Allergy Clin Immunol Pract 2019; 7:2404.</a></li><li><a class="nounderline abstract_t">Caubet JC, Kaiser L, Lemaître B, et al. The role of penicillin in benign skin rashes in childhood: a prospective study based on drug rechallenge. J Allergy Clin Immunol 2011; 127:218.</a></li><li><a class="nounderline abstract_t">Adkinson NF Jr, Thompson WL, Maddrey WC, Lichtenstein LM. Routine use of penicillin skin testing on an inpatient service. N Engl J Med 1971; 285:22.</a></li><li><a class="nounderline abstract_t">Chandra RK, Joglekar SA, Tomas E. Penicillin allergy: anti-penicillin IgE antibodies and immediate hypersensitivity skin reactions employing major and minor determinants of penicillin. Arch Dis Child 1980; 55:857.</a></li><li><a class="nounderline abstract_t">Levine BB, Zolov DM. Prediction of penicillin allergy by immunological tests. J Allergy 1969; 43:231.</a></li><li><a class="nounderline abstract_t">Goldberg A, Confino-Cohen R. Skin testing and oral penicillin challenge in patients with a history of remote penicillin allergy. Ann Allergy Asthma Immunol 2008; 100:37.</a></li><li><a class="nounderline abstract_t">Hunt KJ, Valentine MD, Sobotka AK, et al. A controlled trial of immunotherapy in insect hypersensitivity. N Engl J Med 1978; 299:157.</a></li><li><a class="nounderline abstract_t">Mendelson LM, Ressler C, Rosen JP, Selcow JE. Routine elective penicillin allergy skin testing in children and adolescents: study of sensitization. J Allergy Clin Immunol 1984; 73:76.</a></li><li><a class="nounderline abstract_t">Kamboj S, Yousef E, McGeady S, Hossain J. The prevalence of antibiotic skin test reactivity in a pediatric population. Allergy Asthma Proc 2011; 32:99.</a></li><li><a class="nounderline abstract_t">Macy E, Mangat R, Burchette RJ. Penicillin skin testing in advance of need: multiyear follow-up in 568 test result-negative subjects exposed to oral penicillins. J Allergy Clin Immunol 2003; 111:1111.</a></li><li><a class="nounderline abstract_t">Solensky R, Jacobs J, Lester M, et al. Penicillin Allergy Evaluation: A Prospective, Multicenter, Open-Label Evaluation of a Comprehensive Penicillin Skin Test Kit. J Allergy Clin Immunol Pract 2019; 7:1876.</a></li><li><a class="nounderline abstract_t">Warrington RJ, Burton R, Tsai E. The value of routine penicillin allergy skin testing in an outpatient population. Allergy Asthma Proc 2003; 24:199.</a></li><li><a class="nounderline abstract_t">Vyles D, Chiu A, Routes J, et al. Antibiotic Use After Removal of Penicillin Allergy Label. Pediatrics 2018; 141.</a></li><li><a class="nounderline abstract_t">Bourke J, Pavlos R, James I, Phillips E. Improving the Effectiveness of Penicillin Allergy De-labeling. J Allergy Clin Immunol Pract 2015; 3:365.</a></li><li><a class="nounderline abstract_t">Macy E. Elective penicillin skin testing and amoxicillin challenge: effect on outpatient antibiotic use, cost, and clinical outcomes. J Allergy Clin Immunol 1998; 102:281.</a></li><li><a class="nounderline abstract_t">Solensky R, Earl HS, Gruchalla RS. Lack of penicillin resensitization in patients with a history of penicillin allergy after receiving repeated penicillin courses. Arch Intern Med 2002; 162:822.</a></li><li><a class="nounderline abstract_t">Hershkovich J, Broides A, Kirjner L, et al. Beta lactam allergy and resensitization in children with suspected beta lactam allergy. Clin Exp Allergy 2009; 39:726.</a></li><li><a class="nounderline abstract_t">Parker PJ, Parrinello JT, Condemi JJ, Rosenfeld SI. Penicillin resensitization among hospitalized patients. J Allergy Clin Immunol 1991; 88:213.</a></li><li><a class="nounderline abstract_t">Lopez-Serrano MC, Caballero MT, Barranco P, Martinez-Alzamora F. Booster responses in the study of allergic reactions to beta-lactam antibiotics. J Investig Allergol Clin Immunol 1996; 6:30.</a></li><li><a class="nounderline abstract_t">Dorman SM, Seth S, Khan DA. Risk of Allergic Reactions to Recurrent Intravenous Penicillin Administration in Penicillin Skin Test Negative Patients. J Allergy Clin Immunol Pract 2018; 6:196.</a></li></ol></div><div id="topicVersionRevision">Topic 16503 Version 27.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32446963" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Accuracy of penicillin allergy diagnostic tests: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20934625" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Drug allergy: an updated practice parameter.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17165279" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Safety and effectiveness of a preoperative allergy clinic in decreasing vancomycin use in patients with a history of penicillin allergy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8230623" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Clinical experience with penicillin skin testing in a large inner-city STD clinic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/925260" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Evaluation of penicillin hypersensitivity: value of clinical history and skin testing with penicilloyl-polylysine and penicillin G. A cooperative prospective study of the penicillin study group of the American Academy of Allergy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11101176" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Frequency of systematic reactions to penicillin skin tests.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6267115" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Skin testing to detect penicillin allergy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16937745" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Penicillin skin testing in pregnant women with a history of penicillin allergy and group B streptococcus colonization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33212237" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Penicillin Allergy Assessment in Pregnancy: Safety and Impact on Antibiotic Use.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28333608" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Morbidity in Pregnant Women Associated with Unverified Penicillin Allergies, Antibiotic Use, and Group B Streptococcus Infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31977795" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Prevention of Group B Streptococcal Early-Onset Disease in Newborns: ACOG Committee Opinion, Number 797.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32217968" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Committee Opinion No. 797: Prevention of Group B Streptococcal Early-Onset Disease in Newborns: Correction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17458432" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Penicillin skin testing in patients with a history of beta-lactam allergy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12785408" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : A prospective observational study of the effect of penicillin skin testing on antibiotic use in the intensive care unit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24441667" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Expanding the pool of healthcare providers to perform penicillin skin testing in the ICU.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30928660" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Safety, Efficacy, and Clinical Impact of Penicillin Skin Testing in Immunocompromised Cancer Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28520865" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Impact of an Integrated Antibiotic Allergy Testing Program on Antimicrobial Stewardship: A Multicenter Evaluation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30060208" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Antibiotic allergy testing improves antibiotic appropriateness in patients with cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25959032" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Factors associated with negative histamine control for penicillin allergy skin testing in the inpatient setting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25017533" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Penicillin skin testing is a safe and effective tool for evaluating penicillin allergy in the pediatric population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28483317" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Oral Challenge without Skin Testing Safely Excludes Clinically Significant Delayed-Onset Penicillin Hypersensitivity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9389285" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Skin testing with penicilloate and penilloate prepared by an improved method: amoxicillin oral challenge in patients with negative skin test responses to penicillin reagents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15940154" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Importance of mixture of minor determinants and benzylpenicilloyl poly-L-lysine skin testing in the diagnosis of beta-lactam allergy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17976216" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Oral challenges are needed in the diagnosis of beta-lactam hypersensitivity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17694698" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Assessment of a new brand of determinants for skin testing in a large group of patients with suspected beta-lactam allergy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17694698" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Assessment of a new brand of determinants for skin testing in a large group of patients with suspected beta-lactam allergy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1580706" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Results of the National Institute of Allergy and Infectious Diseases Collaborative Clinical Trial to test the predictive value of skin testing with major and minor penicillin derivatives in hospitalized adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12464043" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Oral antibiotic adverse reactions after penicillin skin testing: multi-year follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17201241" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Elective penicillin skin testing in a pediatric outpatient setting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17650830" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Female sex as a risk factor for penicillin allergy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14162572" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : PENICILLOYL-POLYLYSINE AS AN INTRADERMAL TEST OF PENICILLIN SENSITIVITY.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Clinical experience using only PrePen and penicillin G to detect penicillin allergy in hospitalized patients</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24565482" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Safely diagnosing clinically significant penicillin allergy using only penicilloyl-poly-lysine, penicillin, and oral amoxicillin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7056954" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Penicillin allergy: clinical experience with a battery of skin-test reagents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24856884" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Skin testing only with penicillin G in children with a history of penicillin allergy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1884325" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Drug allergy in cystic fibrosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2253079" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Allergy to penicillin with good tolerance to other penicillins; study of the incidence in subjects allergic to beta-lactams.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8092427" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Immediate allergic reactions to amoxicillin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3232762" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Anaphylaxis to amoxycillin but good tolerance for benzyl penicillin. In vivo and in vitro studies of specific IgE antibodies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8828545" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Cross-reactivity between a penicillin and a cephalosporin with the same side chain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7573820" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Hypersensitivity to cefuroxime with good tolerance to other betalactams.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8837660" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Clinical cross-reactivity between amoxicillin and cephadroxil in patients allergic to amoxicillin and with good tolerance of penicillin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8837660" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Clinical cross-reactivity between amoxicillin and cephadroxil in patients allergic to amoxicillin and with good tolerance of penicillin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21665258" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Clarification concerning amoxicillin skin testing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7897159" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Selective allergic reactions to clavulanic acid.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20159266" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Clavulanic acid can be the component in amoxicillin-clavulanic acid responsible for immediate hypersensitivity reactions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30844483" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : To challenge or not to challenge: Literature data on the positive predictive value of skin tests to beta-lactams.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21035175" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : The role of penicillin in benign skin rashes in childhood: a prospective study based on drug rechallenge.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5089368" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Routine use of penicillin skin testing on an inpatient service.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7436456" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Penicillin allergy: anti-penicillin IgE antibodies and immediate hypersensitivity skin reactions employing major and minor determinants of penicillin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5251662" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Prediction of penicillin allergy by immunological tests.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18254480" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Skin testing and oral penicillin challenge in patients with a history of remote penicillin allergy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/78446" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : A controlled trial of immunotherapy in insect hypersensitivity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6693670" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Routine elective penicillin allergy skin testing in children and adolescents: study of sensitization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21439162" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : The prevalence of antibiotic skin test reactivity in a pediatric population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12743578" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Penicillin skin testing in advance of need: multiyear follow-up in 568 test result-negative subjects exposed to oral penicillins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30878711" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Penicillin Allergy Evaluation: A Prospective, Multicenter, Open-Label Evaluation of a Comprehensive Penicillin Skin Test Kit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12866324" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : The value of routine penicillin allergy skin testing in an outpatient population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29678929" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Antibiotic Use After Removal of Penicillin Allergy Label.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25609352" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Improving the Effectiveness of Penicillin Allergy De-labeling.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9723673" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Elective penicillin skin testing and amoxicillin challenge: effect on outpatient antibiotic use, cost, and clinical outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11926858" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Lack of penicillin resensitization in patients with a history of penicillin allergy after receiving repeated penicillin courses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19178535" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Beta lactam allergy and resensitization in children with suspected beta lactam allergy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1880322" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Penicillin resensitization among hospitalized patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8833166" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Booster responses in the study of allergic reactions to beta-lactam antibiotics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28803185" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Risk of Allergic Reactions to Recurrent Intravenous Penicillin Administration in Penicillin Skin Test Negative Patients.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
